TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial.

A Adenis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.